Alphabet moonshots are ready for launch
Alphabet is considering cutting loose its experimental projects under the "other bets" division, including Verily Life Sciences, as it focuses on AI and capital allocation.
/cloudfront-us-east-2.images.arcpublishing.com/reuters/7WGL4ZKKPBKZ5LNRR4IRTVLA4Q.jpg)
Posted 8/29/2023, 5:50:00 PM
reuters.com
Relevant topic timeline:
Alphabet's AI capabilities are discussed, highlighting potential benefits for investors.